We are live on ! Find out more
OCUL icon

Ocular Therapeutix
OCUL

216 hedge funds and large institutions have $2.2B invested in Ocular Therapeutix in 2025 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 72 increasing their positions, 58 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

183% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 18

105% more call options, than puts

Call options by funds: $22M | Put options by funds: $10.7M

51% more capital invested

Capital invested by funds: $1.45B → $2.2B (+$746M)

24% more repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 58

16% more funds holding

Funds holding: 186 → 216 (+30)

10% more funds holding in top 10

Funds holding in top 10: 10 → 11 (+1)

9.56% more ownership

Funds ownership: 98.59% → 108.15% (+9.6%)

Holders
216
Holders Change
+30
Holders Change %
+16.13%
% of All Funds
2.83%
Holding in Top 10
11
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+10%
% of All Funds
0.14%
New
51
Increased
72
Reduced
58
Closed
18
Calls
$22M
Puts
$10.7M
Net Calls
+$11.2M
Net Calls Change
+$5.65M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$146M
2
Millennium Management
Millennium Management
New York
+$44.7M
3
AllianceBernstein
AllianceBernstein
Tennessee
+$39M
4
ACA
Avoro Capital Advisors
New York
+$34.1M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$32.3M

Top Sellers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
-$28.2M
2
SR
Summer Road
Florida
-$15.6M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$13.7M
4
Franklin Resources
Franklin Resources
California
-$10.9M
5
RA
Rosalind Advisors
Ontario, Canada
-$9.79M
Name Holding Trade Value Shares
Change 		Change in
Stake
Macquarie Group
76
Macquarie Group
Australia
$2.04M -$809K -67,650 -28%
Verition Fund Management
77
Verition Fund Management
Connecticut
$1.94M +$208K +17,431 +12%
ECM
78
ExodusPoint Capital Management
New York
$1.91M +$1.95M +163,132 New
Tudor Investment Corp
79
Tudor Investment Corp
Connecticut
$1.89M +$1.94M +161,899 New
AQR Capital Management
80
AQR Capital Management
Connecticut
$1.71M +$417K +34,854 +31%
AGP
81
Artia Global Partners
Florida
$1.65M +$1.69M +141,061 New
CC
82
Courier Capital
New York
$1.59M -$215K -18,000 -12%
T. Rowe Price Associates
83
T. Rowe Price Associates
Maryland
$1.54M +$62.2K +5,198 +4%
Wells Fargo
84
Wells Fargo
California
$1.53M +$678K +56,702 +76%
State of Wisconsin Investment Board
85
State of Wisconsin Investment Board
Wisconsin
$1.46M -$17.8K -1,487 -1%
SEI Investments
86
SEI Investments
Pennsylvania
$1.36M -$449K -37,556 -24%
GCP
87
GSA Capital Partners
United Kingdom
$1.35M +$1.38M +115,553 New
Two Sigma Advisers
88
Two Sigma Advisers
New York
$1.33M +$1.36M +113,900 New
D.E. Shaw & Co
89
D.E. Shaw & Co
New York
$1.32M +$125K +10,446 +10%
LCM
90
Legato Capital Management
California
$1.32M – – –
BHCM
91
Brevan Howard Capital Management
Jersey
$1.29M +$928K +77,617 +240%
New York State Common Retirement Fund
92
New York State Common Retirement Fund
New York
$1.28M +$135K +11,275 +11%
HS
93
HighVista Strategies
Massachusetts
$1.25M +$212K +17,735 +20%
DekaBank Deutsche Girozentrale
94
DekaBank Deutsche Girozentrale
Germany
$1.24M – – –
Legal & General Group
95
Legal & General Group
United Kingdom
$1.22M -$6.28K -525 -0.5%
California State Teachers Retirement System (CalSTRS)
96
California State Teachers Retirement System (CalSTRS)
California
$1.17M +$130K +10,881 +12%
Truist Financial
97
Truist Financial
North Carolina
$1.17M – – –
MS
98
Maven Securities
Jersey
$1.17M +$1.2M +100,000 New
Brown Advisory
99
Brown Advisory
Maryland
$1.05M – – –
SC
100
Shay Capital
New York
$988K +$1.01M +84,500 New
2 3
4
5 6

OCUL Hedge Fund Activity: Q3 2025 in Review

216 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Ocular Therapeutix (OCUL) for Q3 2025, worth a combined $2.2B — up 51% from $1.45B a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new OCUL positions and 18 closed out — a net gain of 33 holders — while 72 added to existing stakes and 58 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $146M. The largest seller was Deep Track Capital, cutting an estimated $28.2M.

  • 216 institutional investors held Ocular Therapeutix (OCUL) as of Q3 2025, up from 186 in Q2 2025.
  • Funds reported $2.2B of Ocular Therapeutix stock for Q3 2025, up 51% quarter-over-quarter.
  • 51 funds opened new Ocular Therapeutix positions in Q3 2025 and 18 closed out, a net change of +33 holders.
  • The largest Ocular Therapeutix buyer in Q3 2025 was Fidelity Investments, an estimated $146M added.
  • The largest Ocular Therapeutix seller in Q3 2025 was Deep Track Capital, an estimated $28.2M sold.

Based on aggregated 13F filings for Q3 2025.